Global Tyrosine Protein Kinase JAK1 Market By Product Type (AZD-4205, Baricitinib) And By End-Users/Application (Cutaneous Lupus Erythematosus, Eosinophilia) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-985570
  • April 2021
  • Pharmaceuticals
  • 141 Pages

Report Preview

The Tyrosine Protein Kinase JAK1 market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Tyrosine Protein Kinase JAK1 market research report recommends a business strategy for present market participants to strengthen their position in the market.

According to the report, the Tyrosine Protein Kinase JAK1 market size was USD xx million and it is expected to reach USD xx million by the end of 2028, with a CAGR of xx% during 2020-2028. While considering the volume shipments the global Tyrosine Protein Kinase JAK1 market stood at xx (Units/Tons) in 2020 and expected to cross near about xx (units/Tons) by the end of forecast period.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Tyrosine Protein Kinase JAK1 market along with their effects over the forecast period. Similarly, according to the region Tyrosine Protein Kinase JAK1 market research report includes the study of opportunities available in the market situation.

The Tyrosine Protein Kinase JAK1 market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type AZD-4205, Baricitinib, Cerdulatinib, CJ-15314, Others
Applications Cutaneous Lupus Erythematosus, Eosinophilia, Hairy Cell Leukemia, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered AbbVie Inc, Aclaris Therapeutics Inc, Astellas Pharma Inc, AstraZeneca Plc, Bristol-Myers Squibb Co, Chipscreen Biosciences Ltd, CJ HealthCare Corp, Concert Pharmaceuticals Inc, Eli Lilly and Co, Galapagos NV, Incyte Corp, Japan Tobacco Inc, Jiangsu Hengrui Medicine Co Ltd, Nissan Chemical Industries Ltd, Pfizer Inc, Portola Pharmaceuticals Inc, Sareum Holdings Plc, Theravance Biopharma Inc, Vectura Group Plc

Global Tyrosine Protein Kinase JAK1 Market Segmentation by Regions:
In regional analysis, Tyrosine Protein Kinase JAK1 market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Tyrosine Protein Kinase JAK1 market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Tyrosine Protein Kinase JAK1 Market: Value and Forecast
  • U.S.
  • Canada
 
Europe Region for Tyrosine Protein Kinase JAK1 Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 
Asia Pacific Region for Tyrosine Protein Kinase JAK1 Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 
Latin America Region for Tyrosine Protein Kinase JAK1 Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 
Middle East and Africa for Tyrosine Protein Kinase JAK1 Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Global Tyrosine Protein Kinase JAK1 Market Segmentation by Type:
On the basis of product type, global Tyrosine Protein Kinase JAK1 market research report provides the production, revenue, price, and market share and growth rate of each type, primarily split into: AZD-4205, Baricitinib, Cerdulatinib, CJ-15314, Others

Global Tyrosine Protein Kinase JAK1 Market Segmentation by Applications:
On the basis of the end users/applications, Tyrosine Protein Kinase JAK1 research report analyze the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including: Cutaneous Lupus Erythematosus, Eosinophilia, Hairy Cell Leukemia, Others

Major Key Players for Global Tyrosine Protein Kinase JAK1 Market:
The Tyrosine Protein Kinase JAK1 market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. AbbVie Inc, Aclaris Therapeutics Inc, Astellas Pharma Inc, AstraZeneca Plc, Bristol-Myers Squibb Co, Chipscreen Biosciences Ltd, CJ HealthCare Corp, Concert Pharmaceuticals Inc, Eli Lilly and Co, Galapagos NV, Incyte Corp, Japan Tobacco Inc, Jiangsu Hengrui Medicine Co Ltd, Nissan Chemical Industries Ltd, Pfizer Inc, Portola Pharmaceuticals Inc, Sareum Holdings Plc, Theravance Biopharma Inc, Vectura Group Plc

Important Points Covered by Report:
  • To analyze the value of the Tyrosine Protein Kinase JAK1 market, according to the key region.
  • To study the Tyrosine Protein Kinase JAK1 market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Tyrosine Protein Kinase JAK1 market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Tyrosine Protein Kinase JAK1 research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Tyrosine Protein Kinase JAK1 market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Tyrosine Protein Kinase JAK1 market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Tyrosine Protein Kinase JAK1 market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Tyrosine Protein Kinase JAK1 market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Tyrosine Protein Kinase JAK1 market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • AbbVie Inc
  • Aclaris Therapeutics Inc
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Chipscreen Biosciences Ltd
  • CJ HealthCare Corp
  • Concert Pharmaceuticals Inc
  • Eli Lilly and Co
  • Galapagos NV
  • Incyte Corp
  • Japan Tobacco Inc
  • Jiangsu Hengrui Medicine Co Ltd
  • Nissan Chemical Industries Ltd
  • Pfizer Inc
  • Portola Pharmaceuticals Inc
  • Sareum Holdings Plc
  • Theravance Biopharma Inc
  • Vectura Group Plc
  • AZD-4205
  • Baricitinib
  • Cerdulatinib
  • CJ-15314
  • Others
  • Cutaneous Lupus Erythematosus
  • Eosinophilia
  • Hairy Cell Leukemia
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Tyrosine Protein Kinase JAK1 Market Snapshot
          2.1.1. Global Tyrosine Protein Kinase JAK1 Market By Type,2019
               2.1.1.1.AZD-4205
               2.1.1.2.Baricitinib
               2.1.1.3.Cerdulatinib
               2.1.1.4.CJ-15314
               2.1.1.5.Others
          2.1.2. Global Tyrosine Protein Kinase JAK1 Market By Application,2019
               2.1.2.1.Cutaneous Lupus Erythematosus
               2.1.2.2.Eosinophilia
               2.1.2.3.Hairy Cell Leukemia
               2.1.2.4.Others
          2.1.3. Global Tyrosine Protein Kinase JAK1 Market By End-use,2019
          2.1.4. Global Tyrosine Protein Kinase JAK1 Market By Geography,2019

3. Global Tyrosine Protein Kinase JAK1 Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Tyrosine Protein Kinase JAK1 Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Tyrosine Protein Kinase JAK1 Market Size (US$), By Type, 2018 – 2028

5. Global Tyrosine Protein Kinase JAK1 Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Tyrosine Protein Kinase JAK1 Market Size (US$), By Application, 2018 – 2028

6. Global Tyrosine Protein Kinase JAK1 Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Tyrosine Protein Kinase JAK1 Market Size (US$), By End-use, 2018 – 2028

7. Global Tyrosine Protein Kinase JAK1 Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Tyrosine Protein Kinase JAK1 Market Analysis, 2018 – 2028 
          7.2.1. North America Tyrosine Protein Kinase JAK1 Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Tyrosine Protein Kinase JAK1 Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Tyrosine Protein Kinase JAK1 Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Tyrosine Protein Kinase JAK1 Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Tyrosine Protein Kinase JAK1 Market Analysis, 2018 – 2028 
          7.3.1.  Europe Tyrosine Protein Kinase JAK1 Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Tyrosine Protein Kinase JAK1 Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Tyrosine Protein Kinase JAK1 Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Tyrosine Protein Kinase JAK1 Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Tyrosine Protein Kinase JAK1 Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Tyrosine Protein Kinase JAK1 Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Tyrosine Protein Kinase JAK1 Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Tyrosine Protein Kinase JAK1 Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Tyrosine Protein Kinase JAK1 Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Tyrosine Protein Kinase JAK1 Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Tyrosine Protein Kinase JAK1 Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Tyrosine Protein Kinase JAK1 Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Tyrosine Protein Kinase JAK1 Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Tyrosine Protein Kinase JAK1 Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Tyrosine Protein Kinase JAK1 Market Analysis, 2018 – 2028 
          7.6.1.  MEA Tyrosine Protein Kinase JAK1 Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Tyrosine Protein Kinase JAK1 Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Tyrosine Protein Kinase JAK1 Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Tyrosine Protein Kinase JAK1 Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Tyrosine Protein Kinase JAK1 Providers
        8.4.1 AbbVie Inc
                8.1.1 Business Description
                8.1.2 AbbVie Inc Geographic Operations
                8.1.3 AbbVie Inc Financial Information
                8.1.4 AbbVie Inc Product Positions/Portfolio
                8.1.5 AbbVie Inc Key Developments
        8.4.2 Aclaris Therapeutics Inc
                8.2.1 Business Description
                8.2.2 Aclaris Therapeutics Inc Geographic Operations
                8.2.3 Aclaris Therapeutics Inc Financial Information
                8.2.4 Aclaris Therapeutics Inc Product Positions/Portfolio
                8.2.5 Aclaris Therapeutics Inc Key Developments
        8.4.3 Astellas Pharma Inc
                8.3.1 Business Description
                8.3.2 Astellas Pharma Inc Geographic Operations
                8.3.3 Astellas Pharma Inc Financial Information
                8.3.4 Astellas Pharma Inc Product Positions/Portfolio
                8.3.5 Astellas Pharma Inc Key Developments
        8.4.4 AstraZeneca Plc
                8.4.1 Business Description
                8.4.2 AstraZeneca Plc Geographic Operations
                8.4.3 AstraZeneca Plc Financial Information
                8.4.4 AstraZeneca Plc Product Positions/Portfolio
                8.4.5 AstraZeneca Plc Key Developments
        8.4.5 Bristol-Myers Squibb Co
                8.5.1 Business Description
                8.5.2 Bristol-Myers Squibb Co Geographic Operations
                8.5.3 Bristol-Myers Squibb Co Financial Information
                8.5.4 Bristol-Myers Squibb Co Product Positions/Portfolio
                8.5.5 Bristol-Myers Squibb Co Key Developments
        8.4.6 Chipscreen Biosciences Ltd
                8.6.1 Business Description
                8.6.2 Chipscreen Biosciences Ltd Geographic Operations
                8.6.3 Chipscreen Biosciences Ltd Financial Information
                8.6.4 Chipscreen Biosciences Ltd Product Positions/Portfolio
                8.6.5 Chipscreen Biosciences Ltd Key Developments
        8.4.7 CJ HealthCare Corp
                8.7.1 Business Description
                8.7.2 CJ HealthCare Corp Geographic Operations
                8.7.3 CJ HealthCare Corp Financial Information
                8.7.4 CJ HealthCare Corp Product Positions/Portfolio
                8.7.5 CJ HealthCare Corp Key Developments
        8.4.8 Concert Pharmaceuticals Inc
                8.8.1 Business Description
                8.8.2 Concert Pharmaceuticals Inc Geographic Operations
                8.8.3 Concert Pharmaceuticals Inc Financial Information
                8.8.4 Concert Pharmaceuticals Inc Product Positions/Portfolio
                8.8.5 Concert Pharmaceuticals Inc Key Developments
        8.4.9 Eli Lilly and Co
                8.9.1 Business Description
                8.9.2 Eli Lilly and Co Geographic Operations
                8.9.3 Eli Lilly and Co Financial Information
                8.9.4 Eli Lilly and Co Product Positions/Portfolio
                8.9.5 Eli Lilly and Co Key Developments
        8.4.10 Galapagos NV
                8.10.1 Business Description
                8.10.2 Galapagos NV Geographic Operations
                8.10.3 Galapagos NV Financial Information
                8.10.4 Galapagos NV Product Positions/Portfolio
                8.10.5 Galapagos NV Key Developments
        8.4.11 Incyte Corp
                8.11.1 Business Description
                8.11.2 Incyte Corp Geographic Operations
                8.11.3 Incyte Corp Financial Information
                8.11.4 Incyte Corp Product Positions/Portfolio
                8.11.5 Incyte Corp Key Developments
        8.4.12 Japan Tobacco Inc
                8.12.1 Business Description
                8.12.2 Japan Tobacco Inc Geographic Operations
                8.12.3 Japan Tobacco Inc Financial Information
                8.12.4 Japan Tobacco Inc Product Positions/Portfolio
                8.12.5 Japan Tobacco Inc Key Developments
        8.4.13 Jiangsu Hengrui Medicine Co Ltd
                8.13.1 Business Description
                8.13.2 Jiangsu Hengrui Medicine Co Ltd Geographic Operations
                8.13.3 Jiangsu Hengrui Medicine Co Ltd Financial Information
                8.13.4 Jiangsu Hengrui Medicine Co Ltd Product Positions/Portfolio
                8.13.5 Jiangsu Hengrui Medicine Co Ltd Key Developments
        8.4.14 Nissan Chemical Industries Ltd
                8.14.1 Business Description
                8.14.2 Nissan Chemical Industries Ltd Geographic Operations
                8.14.3 Nissan Chemical Industries Ltd Financial Information
                8.14.4 Nissan Chemical Industries Ltd Product Positions/Portfolio
                8.14.5 Nissan Chemical Industries Ltd Key Developments
        8.4.15 Pfizer Inc
                8.15.1 Business Description
                8.15.2 Pfizer Inc Geographic Operations
                8.15.3 Pfizer Inc Financial Information
                8.15.4 Pfizer Inc Product Positions/Portfolio
                8.15.5 Pfizer Inc Key Developments
        8.4.16 Portola Pharmaceuticals Inc
                8.16.1 Business Description
                8.16.2 Portola Pharmaceuticals Inc Geographic Operations
                8.16.3 Portola Pharmaceuticals Inc Financial Information
                8.16.4 Portola Pharmaceuticals Inc Product Positions/Portfolio
                8.16.5 Portola Pharmaceuticals Inc Key Developments
        8.4.17 Sareum Holdings Plc
                8.17.1 Business Description
                8.17.2 Sareum Holdings Plc Geographic Operations
                8.17.3 Sareum Holdings Plc Financial Information
                8.17.4 Sareum Holdings Plc Product Positions/Portfolio
                8.17.5 Sareum Holdings Plc Key Developments
        8.4.18 Theravance Biopharma Inc
                8.18.1 Business Description
                8.18.2 Theravance Biopharma Inc Geographic Operations
                8.18.3 Theravance Biopharma Inc Financial Information
                8.18.4 Theravance Biopharma Inc Product Positions/Portfolio
                8.18.5 Theravance Biopharma Inc Key Developments
        8.4.19 Vectura Group Plc
                8.19.1 Business Description
                8.19.2 Vectura Group Plc Geographic Operations
                8.19.3 Vectura Group Plc Financial Information
                8.19.4 Vectura Group Plc Product Positions/Portfolio
                8.19.5 Vectura Group Plc Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Tyrosine Protein Kinase JAK1 Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Tyrosine Protein Kinase JAK1 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Tyrosine Protein Kinase JAK1 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Tyrosine Protein Kinase JAK1 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Tyrosine Protein Kinase JAK1 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Tyrosine Protein Kinase JAK1 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Tyrosine Protein Kinase JAK1 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Tyrosine Protein Kinase JAK1 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Tyrosine Protein Kinase JAK1 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Tyrosine Protein Kinase JAK1 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Tyrosine Protein Kinase JAK1 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Tyrosine Protein Kinase JAK1 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Tyrosine Protein Kinase JAK1 Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Tyrosine Protein Kinase JAK1 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Tyrosine Protein Kinase JAK1 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Tyrosine Protein Kinase JAK1 Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Tyrosine Protein Kinase JAK1: Market Segmentation 
FIG. 2 Global Tyrosine Protein Kinase JAK1 Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Tyrosine Protein Kinase JAK1 Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Tyrosine Protein Kinase JAK1 Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Tyrosine Protein Kinase JAK1 Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Tyrosine Protein Kinase JAK1 Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Tyrosine Protein Kinase JAK1 Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Tyrosine Protein Kinase JAK1 Providers, 2019
FIG. 11 Global Tyrosine Protein Kinase JAK1 Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Tyrosine Protein Kinase JAK1 Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Tyrosine Protein Kinase JAK1 Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Tyrosine Protein Kinase JAK1 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Tyrosine Protein Kinase JAK1 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Tyrosine Protein Kinase JAK1 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Tyrosine Protein Kinase JAK1 Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Tyrosine Protein Kinase JAK1 Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Tyrosine Protein Kinase JAK1 market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Tyrosine Protein Kinase JAK1 Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Tyrosine Protein Kinase JAK1 Market Value, By Segment1, 2018 – 2028
TABLE  North America Tyrosine Protein Kinase JAK1 Market Value, By Segment2, 2018 – 2028
TABLE  North America Tyrosine Protein Kinase JAK1 Market Value, By Country, 2018 – 2028
TABLE  Europe Tyrosine Protein Kinase JAK1 Market Value, By Segment1, 2018 – 2028
TABLE  Europe Tyrosine Protein Kinase JAK1 Market Value, By Segment2, 2018 – 2028
TABLE  Europe Tyrosine Protein Kinase JAK1 Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Tyrosine Protein Kinase JAK1 Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Tyrosine Protein Kinase JAK1 Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Tyrosine Protein Kinase JAK1 Market Value, By Country, 2018 – 2028
TABLE  Latin America Tyrosine Protein Kinase JAK1 Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Tyrosine Protein Kinase JAK1 Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Tyrosine Protein Kinase JAK1 Market Value, By Country, 2018 – 2028
TABLE  MEA Tyrosine Protein Kinase JAK1 Market Value, By Segment1, 2018 – 2028
TABLE  MEA Tyrosine Protein Kinase JAK1 Market Value, By Segment2, 2018 – 2028
TABLE  MEA Tyrosine Protein Kinase JAK1 Market Value, By Country, 2018 – 2028
TABLE  AbbVie Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Aclaris Therapeutics Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Astellas Pharma Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Myers Squibb Co: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Chipscreen Biosciences Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CJ HealthCare Corp: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Concert Pharmaceuticals Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly and Co: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Galapagos NV: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Incyte Corp: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Japan Tobacco Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Jiangsu Hengrui Medicine Co Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Nissan Chemical Industries Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Portola Pharmaceuticals Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sareum Holdings Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Theravance Biopharma Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Vectura Group Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Tyrosine Protein Kinase JAK1 Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Tyrosine Protein Kinase JAK1 Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Tyrosine Protein Kinase JAK1 Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Tyrosine Protein Kinase JAK1 Market, By Geography, 2019 (US$ Mn)
FIG.  Global Tyrosine Protein Kinase JAK1 Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Tyrosine Protein Kinase JAK1 Providers, 2016
FIG.  Global Tyrosine Protein Kinase JAK1 Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global AZD-4205 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Baricitinib Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cerdulatinib Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global CJ-15314 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Tyrosine Protein Kinase JAK1 Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Cutaneous Lupus Erythematosus Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Eosinophilia Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Hairy Cell Leukemia Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Tyrosine Protein Kinase JAK1 Market Value, 2018 – 2028, (US$ Mn)